FDA approves first oral COVID-19 treatment for emergency use in mild to moderate COVID cases

This image provided by Pfizer in October 2021 shows the company's COVID-19 Paxlovid pills. U.S. health regulators on Wednesday, Dec. 22, 2021 authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. (Pfizer via AP)

This image provided by Pfizer in October 2021 shows the company’s COVID-19 Paxlovid pills. (Pfizer via AP)

OAN Newsroom
UPDATED 5:07 PM PT – Wednesday, December 22, 2021

The Food and Drug Administration approved the first COVID anti-viral pill treatment for emergency use.

On Wednesday, the FDA authorized Pfizer’s “Paxlovid” for the treatment of mild to moderate coronavirus cases in high-risk individuals. The treatment consists of three different pills.

The FDA stressed the treatment isn’t for people experiencing severe disease and has not been approved as a preventative against COVID-19. It is however, available for those as young as 12 that weigh at least 88 pounds.

The FDA noted it’s also not an alternative to COVID vaccines and have encouraged people to still get inoculated. Meanwhile, the federal government announced last month it would purchase 10 million courses of the drug in a $5 billion deal.

MORE NEWS: CDC Director Walensky Dodges Question About Preparation For Omicron Variant

Source link

Author: carleyshaffer1

Be the first to comment

Leave a Reply

Your email address will not be published.